DENVER, Colorado – Zynex, Inc. (NASDAQ: ZYXI) recently held its Q4 2024 Earnings Conference Call on March 11, 2025, at 4:15 PM ET. The conference call featured key executives from the company, including Chairman, President, and CEO Thomas Sandgaard, CFO Dan Moorhead, COO Anna Lucsok, and President of Zynex Monitoring Solutions, Donald Gregg.
During the call, Brian Prenoveau, Investor Relations at Zynex, provided an overview of the financial results for the fourth quarter and year-ended December 31, 2024. Participants had the opportunity to hear about the company’s performance and future projections, with a focus on important factors affecting Zynex’s operations and growth strategies.
Throughout the conference call, executives emphasized the importance of reviewing the company’s SEC filings to gain a comprehensive understanding of Zynex’s position in the market. They highlighted key factors influencing the company’s product development, regulatory environment, sales and marketing strategies, and overall operating performance.
Thomas Sandgaard, in his address during the call, reiterated the company’s commitment to innovation and growth, outlining key areas of focus for the future. Dan Moorhead provided insights into the financial aspects of the business, while Anna Lucsok delved into operational strategies. Donald Gregg shared updates on Zynex Monitoring Solutions and its role within the company’s broader portfolio.
Investors and analysts, including Jeffrey Cohen from Ladenburg and Yi Chen from H.C. Wainwright & Co., had the opportunity to engage with the executives during the question-and-answer session that followed the formal presentation. The call was recorded for reference purposes, ensuring transparency and accountability in communication with stakeholders.
Overall, the Zynex Q4 2024 Earnings Conference Call provided a comprehensive overview of the company’s performance, strategic outlook, and key areas of focus for the future. With a strong leadership team in place, Zynex remains well-positioned to navigate challenges and capitalize on opportunities in the evolving healthcare landscape.
